WHY DIDN'T ABBOTT LABS CORRECT PROBLEMS, FIRST DETECTED IN 2019, THAT CAUSED BABY FORMULA FROM THIS PLANT TO BECOME INFECTED WITH DANGEROUS BACTERIA? ON APRIL 20, 2022 ABBOTT LABS REPORTED $1.73 EARNINGS PER SHARE FOR THE QUARTER, BEATING THE CONSENSUS ESTIMATE OF $1.47 BY $0.26. THEY EARNED $11.90 BILLION FOR THE QUARTER, COMPARED TO THE CONSENSUS ESTIMATE OF $11 BILLION. ACCEPTING RESPONSIBILITY AND DOING THE RIGHT THING COSTS MONEY.
